Advanced Medical Solutions Group PLC
LSE:AMS
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
179.2
254
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Advanced Medical Solutions Group PLC
Advanced Medical Solutions Group PLC
Cost of Revenue
Advanced Medical Solutions Group PLC
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Advanced Medical Solutions Group PLC
LSE:AMS
|
Cost of Revenue
-£59.7m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
|
Abingdon Health PLC
LSE:ABDX
|
Cost of Revenue
-£2m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
ConvaTec Group PLC
LSE:CTEC
|
Cost of Revenue
-$920m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Tristel PLC
LSE:TSTL
|
Cost of Revenue
-£6.9m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-6%
|
|
|
Inspecs Group PLC
LSE:SPEC
|
Cost of Revenue
-£99.7m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
Cambridge Nutritional Sciences PLC
LSE:CNSL
|
Cost of Revenue
-£3.7m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Advanced Medical Solutions Group PLC
Glance View
Advanced Medical Solutions Group Plc engages in the design, development, manufacture and distribution of wound care products, surgical dressings, medical grade materials, and medical adhesives and sutures for closing and sealing tissue. The company is headquartered in Winsford, Cheshire. The company went IPO on 2002-04-30. The firm operates through two business units for its sales, marketing and research and development (R&D) activities. Surgical business unit is focused on selling and marketing its branded products and are sold directly and through its distributors. Wound care business unit is focused on distribution and marketing its products that are supplied to medical device partners under its own brands. The Company’s products include ActivHeal, LiquiBand and RESORBA. Its technologies include collagen, cyanoacrylates, internal sealants, oxidized cellulose, sutures, alginates, foams, hydrocolloid and hydrogel.
See Also
What is Advanced Medical Solutions Group PLC's Cost of Revenue?
Cost of Revenue
-59.7m
GBP
Based on the financial report for Jun 30, 2024, Advanced Medical Solutions Group PLC's Cost of Revenue amounts to -59.7m GBP.
What is Advanced Medical Solutions Group PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-9%
Over the last year, the Cost of Revenue growth was -10%. The average annual Cost of Revenue growth rates for Advanced Medical Solutions Group PLC have been -10% over the past three years , -8% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
